IDYA Jul 2024 40.000 put
| Previous close | 3.8000 |
| Open | 3.1000 |
| Bid | 4.3000 |
| Ask | 6.9000 |
| Strike | 40.00 |
| Expiry date | 2024-07-19 |
| Day's range | 3.1000 - 3.8000 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
PR NewswireIDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on May 30, 2024, the Compensation Committee of IDEAYA's Board of Directors granted non-qualified stock options to purchase an aggregate of 49,000 shares of the Company's common stock to two newly hired employees. The stock options were granted under the IDEAYA Biosciences, Inc. 2023 Employment Inducement Incentive Award Plan (20
- PR Newswire
IDEAYA Biosciences to Participate in Upcoming June 2024 Investor Relations Events
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in the upcoming investor relations events.
- PR Newswire
IDEAYA Biosciences Appoints Daniel A. Simon as Chief Business Officer to Lead Corporate Strategy and Business Development
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that Daniel A. Simon, will join the company as its Chief Business Officer in August 2024.
